Algert Global LLC Syros Pharmaceuticals, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$4.46 - $9.2 $144,013 - $297,068	-32,290 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$4.52 - $10.1 $145,950 - $326,129	32,290 New	32,290 $223,000
Q3 2019 Nov 14, 2019	SELL	$7.14 - $11.65 $127,948 - $208,768	-17,920 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $98,560 - $174,720	17,920 New	17,920 $166,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.